Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cannabis and Oral THC for Spasticity in MS
NCT00682929Phase 2Terminated
- Sponsor
- University of California, Davis
- Start
- Apr 2004
- Primary completion
- Aug 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cannabis, dronabinol in multiple sclerosis (MS), sponsored by University of California, Davis. Started Apr 2004; status: terminated.
02
Drugs
cannabisdronabinol
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT00682929.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00682929.